Annual report pursuant to Section 13 and 15(d)

Organization, Plan of Business Operations (Details)

v3.23.1
Organization, Plan of Business Operations (Details)
 1 Months Ended
Sep. 23, 2022
USD ($)
shares
Sep. 22, 2022
shares
Jul. 25, 2022
Vote
shares
Feb. 08, 2019
USD ($)
$ / shares
shares
Jul. 31, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Oct. 31, 2022
shares
May 11, 2022
USD ($)
Dec. 31, 2021
USD ($)
shares
Nov. 12, 2018
USD ($)
Organization, Plan of Business Operations                    
Reverse stock split ratio 15                  
Reduction in common shares authorized           20,000,000 949,900   20,000,000  
Voting power     99              
Percentage of voting power of the company's capital stock held by holders, signed the written consent     73.00%              
Accumulated deficit | $           $ 80,551,000     $ 76,999,000  
Cash received instead of reverse stock split | $ $ 9,580                  
General and administrative expense                    
Organization, Plan of Business Operations                    
Business combination, consideration transferred | $         $ 1,900,000          
Invagen Pharmaceuticals Inc [Member]                    
Organization, Plan of Business Operations                    
Percentage of shares repurchased               100.00%    
Minimum                    
Organization, Plan of Business Operations                    
Reverse stock split ratio     10              
Reduction in common shares authorized 20,000,000   20,000,000              
Maximum                    
Organization, Plan of Business Operations                    
Reverse stock split ratio     20              
Reduction in common shares authorized 50,000,000   50,000,000              
Invagen Pharmaceuticals Inc [Member]                    
Organization, Plan of Business Operations                    
Percentage of repurchase of ownership interest               100.00%    
Invagen Pharmaceuticals Inc [Member]                    
Organization, Plan of Business Operations                    
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned | $                   $ 35,000,000
Percentage of equity interest agreed to acquire in first stage                   33.30%
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned, Remaining Purchase Amount | $                   $ 180,000,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares       388,888            
Business Acquisition, Share Price | $ / shares       $ 90.00            
Business acquisition shares acquisition for net proceeds | $       $ 31,500,000            
Invagen Pharmaceuticals Inc [Member] | Invagen Pharmaceuticals Inc [Member]                    
Organization, Plan of Business Operations                    
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners       33.30%            
Common Shares                    
Organization, Plan of Business Operations                    
Number of shares held by holders of Company's stock, signed the written consent     9,423,429              
Number of votes per share | Vote     1              
Number of fraction shares in new common stock   1                
Common Shares | Invagen Pharmaceuticals Inc [Member] | Minimum                    
Organization, Plan of Business Operations                    
Percentage of repurchase of ownership interest                   75.00%
Common Shares | Invagen Pharmaceuticals Inc [Member]                    
Organization, Plan of Business Operations                    
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares         388,888          
Class A Preferred Shares                    
Organization, Plan of Business Operations                    
Number of shares held by holders of Company's stock, signed the written consent     250,000              
Voting power     1.1              
Fortress | Contribution Agreement                    
Organization, Plan of Business Operations                    
Ownership percentage transferred               100.00%    
Fortress | Contribution Agreement | Minimum                    
Organization, Plan of Business Operations                    
Proceeds from equity financing | $               $ 7,500,000